Vertex Pharmaceuticals Incorporated (VRTX) by event type
VRTX moves most on analyst upgrades — a median of +0.35% at 30 minutes across 64 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the VRTX overview →
How VRTX reacts across 6 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 536 of 2,717 | 64 | +0.35% | 66% | +0.26% |
| Analyst downgrades 1,914 of 2,603 | 54 | -0.22% | 39% | -0.89% |
| Coverage initiations 669 of 2,283 | 28 | +0.24% | 64% | +0.66% |
| Rating reiterations 1,547 of 3,522 | 217 | +0.01% | 51% | +0.05% |
| Price-target raises 1,063 of 1,790 | 71 | -0.03% | 47% | +0.06% |
| Price-target cuts 1,188 of 1,527 | 32 | -0.16% | 38% | -0.12% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.
That’s how VRTX usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · VRTX overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CESCA THERAPEUTICS INC COMMON (KOOL) | 736 | -0.01% | 37% |
| AIMMUNE THERAPEUTICS (AIMT) | 734 | -0.29% | 40% |
| AbbVie Inc. (ABBV) | 731 | 0.00% | 50% |
| INSYS THERAPEUTICS (INSY) | 731 | +0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.